UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
|
|
FORM 8-K
CURRENT REPORT
Pursuant To Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (date of earliest event reported): July 22, 2005
|
ANGIODYNAMICS, INC. |
(Exact Name of Registrant as Specified in its Charter)
|
Delaware |
(State or Other Jurisdiction of Incorporation)
|
|
0-50761 |
|
11-3146460 |
| |
|
(Commission File Number) |
(IRS Employer Identification No.) | ||||
|
603 Queensbury Avenue, Queensbury, New York |
|
12804 |
| ||
|
|
(Address of Principal Executive Offices) |
(Zip Code) | |||
|
(518) 798-1215 |
(Registrant’s telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions.
|
o |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
o |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
o |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|
o |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
|
Item 2.02. |
Results of Operations and Financial Condition |
|
Item 7.01 |
Regulation FD Disclosure |
The following information is furnished pursuant to both Item 2.02 and Item 7.01
On July 22, 2005, AngioDynamics, Inc. issued a press release announcing its financial results for the thirteen and fifty-two weeks ended May 28, 2005. A copy of the release is attached hereto as Exhibit 99.1 and is incorporated herein by reference in its entirety.
|
Item 9.01 |
Financial Statements and Exhibits |
|
(c) |
Exhibits |
|
99.1 |
Press Release issued by AngioDynamics, Inc. on July 22, 2005, regarding financial results for the thirteen and fifty-two weeks ended May 28, 2005. |
2
SIGNATURES:
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
Date: July 22, 2005 |
ANGIODYNAMICS, INC. |
(Registrant)
|
By: /s/ Joseph G. Gerardi |
Joseph G. Gerardi
Vice President, Chief Financial Officer
3
EXHIBIT INDEX
|
Exhibit |
Description |
|
99.1 |
Press Release issued by AngioDynamics, Inc. on July 22, 2005, regarding financial results for the thirteen and fifty-two weeks ended May 28, 2005. |
4